The Indian Competition Authority opens investigation into abuse of dominance by syringe manufacturer and a group of hospitals (Vivek Sharma / Becton Dickinson India / Max Super Speciality Hospital)

Sharma, Man Mohan

Previous article The Turkish Competition Authority publishes a reasoned decision on the pharmaceutical industry (Turkish Pharmacists Association) Next article The Düsseldorf Regional Court orders injunctive relief for infringement of standard-essential patents in the first German judgments after CJEU decision on FRAND (Sisvel / Haier)

17 Nov 2015

The Indian Competition Authority opens investigation into abuse of dominance by syringe manufacturer and a group of hospitals (Vivek Sharma / Becton Dickinson India / Max Super Speciality Hospital)

KEYWORDS

Reference

Competition Commission of India, Vivek Sharma / Becton Dickinson India / Max Super Speciality Hospital, Case No. 77/2015, 17 November 2015

CCI initiates investigation against Max Super Specialty Hospitals for alleged abuse of dominance* The CCI in its order dated November 17,

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Man Mohan Sharma
Vaish Associates Advocates (New Delhi)

India 263 contributions 40478 visits

Quotation

Man Mohan Sharma, The Indian Competition Authority opens investigation into abuse of dominance by syringe manufacturer and a group of hospitals (Vivek Sharma / Becton Dickinson India / Max Super Speciality Hospital), 17 November 2015, e-Competitions Exclusive rights (Art. 106 TFEU), Art. N° 87746

Visites 120